Trastuzumab
CAS 180288-69-1 3 FDA-DMF suppliersBiologic
Overview
Trastuzumab is a monoclonal antibody used as a targeted therapy for certain types of breast cancer that are HER2-positive. It works by binding to the HER2 receptor on cancer cells, inhibiting their growth and survival.
Therapeutic areas
OncologyBreast CancerGastroesophageal Cancer
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.